Interview

Telix Pharmaceuticals acquires Swiss-German counterpart December 1, 2020

Australian biotechnology company Telix Pharmaceuticals has announced it will acquire Swiss-German counterpart TheraPharm for its portfolio of potential diagnostics and treatments for haematological diseases like blood cancer.

Dimerix announces a new COVID-19 study for DMX-200 December 1, 2020

Clinical-stage company Dimerix (ASX:DXB) has announced its lead candidate DMX-200 will enter a second clinical study in COVID-19 patients.

Australian invention deployed as first instant patient isolation room December 1, 2020

An Australian invention has become the world's first deployed hospital instant patient isolation room to support the health response to COVID-19.

AusBiotech showcases Australia’s clinical trials advantages during JP Morgan December 1, 2020

AusBiotech is set to showcase the globally-recognised strength of the Australian clinical trials sector during JP Morgan week in January 2021.

Sydney research discovery could lead to new cancer therapies December 1, 2020

Researchers at Children’s Medical Research Institute (CMRI) in Westmead, Sydney, say they have made an unexpected discovery about cancer cells.

TGA registration for Rhinomed's new nasal swab November 26, 2020

Nasal airway and respiratory technology company Rhinomed (ASX:RNO) has announced the TGA has registered its high load capturing nasal swab as a Class 1 device.

Telix submits prostate cancer imaging product to FDA November 26, 2020

Telix Pharmaceuticals (ASX:TLX) has filed a new drug application with the US FDA for its radiopharmaceutical targeting ProstateSpecific Membrane Antigen for the imaging of prostate cancer using Positron Emission Tomography.

Race Oncology updates on results of Bisantrene study November 26, 2020

Race Oncology (ASX: RAC) has shared the results of the preclinical research program it is undertaking as part of a collaboration with The University of Newcastle.

Stem cell news 'the most unexpected result of my career’ November 26, 2020

Sydney scientists investigating telomeres and stem cells have reported what a leading Australian researcher calls “the most unexpected result of my career’’.

Oventus signs agreement to expand distribution in US November 26, 2020

Obstructive sleep apnea company Oventus Medical (ASX:OVN) has signed a marketing agreement with VGM & Associates.

Industry update highlights SA opportunities November 26, 2020

Clinical trials, immediate initiatives and long-term strategies to support life sciences at a State and national level were highlighted at AusBiotech’s SA Industry Update.

Monash to leverage MRFF funds in AMR fight November 24, 2020

Monash University has a new project that aims to use a range of new technologies to help address one of the world's most serious health issues, antimicrobial resistance.

Most Read

AusBiotech showcases Australia’s clinical trials advantages during JP Morgan

Australian invention deployed as first instant patient isolation room

Dimerix announces a new COVID-19 study for DMX-200

Telix Pharmaceuticals acquires Swiss-German counterpart

Sydney research discovery could lead to new cancer therapies

New Stories

Telix Pharmaceuticals acquires Swiss-German counterpart

Dimerix announces a new COVID-19 study for DMX-200

Australian invention deployed as first instant patient isolation room

AusBiotech showcases Australia’s clinical trials advantages during JP Morgan

Sydney research discovery could lead to new cancer therapies

TGA registration for Rhinomed's new nasal swab

Telix submits prostate cancer imaging product to FDA

Sign In

Most Read

AusBiotech showcases Australia’s clinical trials advantages during JP Morgan

Australian invention deployed as first instant patient isolation room

Dimerix announces a new COVID-19 study for DMX-200

Telix Pharmaceuticals acquires Swiss-German counterpart

Sydney research discovery could lead to new cancer therapies

Follow Us

New Stories

Telix Pharmaceuticals acquires Swiss-German counterpart

Dimerix announces a new COVID-19 study for DMX-200

Australian invention deployed as first instant patient isolation room

AusBiotech showcases Australia’s clinical trials advantages during JP Morgan

Sydney research discovery could lead to new cancer therapies

TGA registration for Rhinomed's new nasal swab

Telix submits prostate cancer imaging product to FDA